Skip to main content
. Author manuscript; available in PMC: 2014 Oct 9.
Published in final edited form as: Helicobacter. 2011 Apr;16(2):139–145. doi: 10.1111/j.1523-5378.2011.00828.x

Table 3.

Adverse events of 14-day hybrid therapy

Adverse Events Hybrid therapy (n = 117)
Abdominal pain 4 (1/2/1)
Constipation 0 (0/0/0)
Diarrhea 8 (6/1/1)
Dizziness 6 (4/1/1)
Taste perversion 8 (7/1/0)
Headache 5 (4/1/0)
Anorexia 1 (1/0/0)
Nausea 3 (0/1/2)
Vomiting 2 (0/1/1)
Skin rash 1 (0/0/1)
Fatigue 2 (2/0/0)
Others 4 (2/1/1)
a

Numbers of patients who suffered from mild, moderate and severe adverse events.